Isoflavone Intake is Associated With Decreased Chronic Obstructive Pulmonary Disease Morbidity.

Area of Science:

• Nutritional Science
• Respiratory Medicine
• Cardiovascular Health

Background:

• Isoflavones, plant compounds in soy, are known for cardiovascular benefits.
• Their impact on respiratory diseases, specifically chronic obstructive pulmonary disease (COPD), remains largely unexplored.

Purpose of the Study:

• To investigate the association between dietary isoflavone intake and respiratory morbidity in former smokers with COPD.
• To explore the relationship between isoflavone intake and biomarkers of platelet activation, inflammation, and oxidative stress.

Main Methods:

• A prospective cohort study of former smokers with COPD.
• Assessment of respiratory morbidity using validated questionnaires (CAT, CCQ, mMRC, SGRQ, ECSC) and spirometry.
• Dietary isoflavone intake was quantified, and associations were analyzed using regression models adjusted for covariates.

Main Results:

• Increased total isoflavone intake was significantly associated with lower scores on the COPD Assessment Test (CAT), Clinical COPD Questionnaire (CCQ), and Ease of Cough and Sputum Clearance (ECSC).
• Higher isoflavone intake correlated with reduced urinary 11-dehydro-thromboxane B2, a marker of platelet activation.
• No significant associations were found between isoflavone intake and modified Medical Research Council (mMRC) scores or exacerbation rates.

Conclusions:

• Higher dietary isoflavone intake is linked to improved respiratory symptom scores in individuals with COPD.
• Reduced platelet activation observed with higher isoflavone intake suggests a potential mechanism for improved COPD morbidity.
• Dietary interventions focusing on isoflavones may offer a novel strategy for managing COPD.